ReviewRedox biology2026
Mitochondrial homeostasis imbalance-triggered PANoptosis in traumatic brain and spinal cord injury: from mechanism to therapeutic strategies.
Review in Redox biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traumatic injury to the central nervous system (CNS), also known as traumatic brain injury (TBI) and spinal cord injury (SCI), is characterized by high disability and mortality worldwide. PANoptosis is a newly identified cell death mode that synergistically initiates pyroptosis, apoptosis and necroptosis via activation of PANoptosome. It is closely associated with oxidative stress, neuroinflammation, and secondary injury following TBI and SCI, yet the key pathogenic factors and mechanisms underlying PANoptosis remain incompletely elucidated. Mitochondria, as a central organelle for energy synthesis and oxidative stress, its health and homeostasis are the cornerstone of cell survival and biological function. Emerging evidence suggests that the loss of mitochondrial homeostasis plays a fundamental role in the activation and execution of PANoptosis across various cell types. Here, we review the detailed manifestations of mitochondrial homeostasis imbalance in TBI and SCI, such as impaired biogenesis, abnormal dynamics, mitophagy dysfunction, and mitochondria-derived vesicles. Meanwhile, we systematically analyze the characteristics and pathological effects of PANoptosis cascade following TBI and SCI, with a focus on the regulatory patterns, mechanisms, and potential targets of injured mitochondria driving PANoptosis. In addition, we discuss the advancements and future perspectives of mitochondria-based strategies for modulating PANoptosis in TBI and SCI. Taken together, despite considerable challenges in governing post-traumatic mitochondria homeostasis, its multiple targeting of the upstream PANoptosome and downstream cell death signaling offers a promising approach to improve the outcome of CNS trauma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.